Sirijatuphat Rujipas, Nookeu Pornboonya, Thamlikitkul Visanu
Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Open Forum Infect Dis. 2020 Sep 7;7(10):ofaa411. doi: 10.1093/ofid/ofaa411. eCollection 2020 Oct.
To determine the effectiveness of implementing a locally developed clinical practice guideline (CPG) for antibiotic treatment in adults with community-acquired cellulitis at Siriraj Hospital in Bangkok, Thailand.
The CPG for antibiotic treatment of community-acquired cellulitis was developed based on local data during June to December 2016. The CPG was introduced by multifaceted interventions, including posters, brochures, circular letters, social media, conference, classroom training, and interactive education during January to September 2018.
Among 360 patients with community-acquired cellulitis, 84.4% were ambulatory and 15.6% were hospitalized. The median age of patients was 62 years, and 59.4% were female. Antibiotic prescription according to CPG (CPG-compliant group) was observed in 251 patients (69.7%), and CPG noncompliance was found in 109 patients (30.3%) (CPG-noncompliant group). The demographics and characteristics of patients were comparable between groups. Patients in the CPG-compliant group had a significantly lower rate of intravenous antibiotics (18.7% vs 33.9%, = .007), lower prescription rate of broad-spectrum antibiotics (14.7% vs 78.9%, < .001) and antibiotic combination (6.4% vs 13.8%, = .022), shorter median duration of antibiotic treatment (7 vs 10 days, < .001), lower median cost of antibiotic treatment (US $3 vs $7, < .001), and lower median hospitalization cost (US $601 vs $1587, = .008) than those in the CPG-noncompliant group. Treatment outcomes were not significantly different between groups.
Adherence to CPG seems to reduce inappropriate prescription of broad-spectrum antibiotic or antibiotic combination and treatment costs in adults with community-acquired cellulitis without differences in favorable outcomes or adverse events.
为确定在泰国曼谷诗里拉吉医院实施本地制定的社区获得性蜂窝织炎成人抗生素治疗临床实践指南(CPG)的有效性。
基于2016年6月至12月的本地数据制定社区获得性蜂窝织炎抗生素治疗的CPG。2018年1月至9月期间,通过多方面干预措施引入该CPG,包括海报、宣传册、通函、社交媒体、会议、课堂培训和互动教育。
在360例社区获得性蜂窝织炎患者中,84.4%为门诊患者,15.6%为住院患者。患者的中位年龄为62岁,59.4%为女性。251例患者(69.7%)的抗生素处方符合CPG(CPG依从组),109例患者(30.3%)存在CPG不依从情况(CPG不依从组)。两组患者的人口统计学和特征具有可比性。CPG依从组患者静脉使用抗生素的比例显著较低(18.7%对33.9%,P = 0.007),广谱抗生素的处方率较低(14.7%对78.9%,P < 0.001)以及抗生素联合使用的比例较低(6.4%对13.8%,P = 0.022),抗生素治疗的中位持续时间较短(7天对10天,P < 0.001),抗生素治疗的中位费用较低(3美元对7美元,P < 0.001),住院中位费用较低(601美元对1587美元,P = 0.008),均低于CPG不依从组。两组间治疗结局无显著差异。
遵循CPG似乎可减少社区获得性蜂窝织炎成人患者中广谱抗生素或抗生素联合使用的不适当处方以及治疗费用,且在良好结局或不良事件方面无差异。